Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 4/20 | 0.48 |
| ▸ | METAP1 | P53582 | 2/20 | 0.48 |
| ▸ | PPID | Q08752 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | DRD1 | P21728 | 1/20 | 0.36 |
| ▸ | MARS1 | P56192 | 4/20 | 0.36 |
| ▸ | CTSC | P53634 | 1/20 | 0.35 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7762932 | 0.81 | METAP2 (0.50) | METAP2METAP1PPIDMARS1CTSC | |
| SCHEMBL7766540 | 0.81 | METAP2 (0.50) | METAP2METAP1PPIDMARS1CTSC | |
| SCHEMBL28969923 | 0.79 | DPP4 (0.46) | METAP2METAP1ALDH1A1SOAT1 | |
| SCHEMBL28969856 | 0.78 | ALDH1A1 (0.43) | METAP2METAP1ALDH1A1SOAT1 | |
| SCHEMBL28969920 | 0.78 | GNAI3 (0.50) | — | |
| SCHEMBL113612 | 0.78 | METAP2 (0.53) | METAP2METAP1PPIDMARS1 | |
| SCHEMBL5443843 | 0.78 | METAP2 (0.53) | METAP2METAP1PPIDMARS1 | |
| SCHEMBL113611 | 0.78 | METAP2 (0.53) | METAP2METAP1PPIDMARS1 | |
| SCHEMBL28969889 | 0.77 | ALDH1A1 (0.41) | METAP2METAP1ALDH1A1SOAT1 | |
| Hydrochloric Acid SCHEMBL2031642 | 0.76 | METAP2 (0.51) | METAP2METAP1PPIDMARS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115835860-A | Novel analogues of pterostilbene amino acids with carbonate for the treatment of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis | 树顶分子生技股份有限公司 | 2023-03-21 | — | — | CN | disclosed |